Skip to main content

Table 2 Microbiological and analytical characteristics

From: Prospective comparative multi-centre study on imported Plasmodium ovale wallikeri and Plasmodium ovale curtisi infections

  P ovale curtisi
(n = 35)
P ovale wallikeri
(n = 44)
p
Positive thick smear 28/34 (82.4) 36/42 (85.7) 0.689
Only PCR positive 5 (18.5) 6 (19.4) 1
Parasitaemia, median × µL (IQR) 2550 (647.5–11,677.5) 946 (600–4450) 0.441
Parasitaemia index    0.275
 Very low ≤ 0.01% 3/22 (13.6) 7/28 (25.0)  
 Low 0.02–0.1% 8/22 (36.4) 13/28 (46.4)  
 Medium > 0.1% 11/22 (50.0) 8/28 (28.6)  
Rapid diagnostic test
 Common antigen positive 6/23 (26.1) 14/33 (42.4) 0.209
 P. falciparum antigen positive 0/23 (0.0) 3/33 (9.1) 0.502
Total WBC count, median cells/µL (IQR) 5600 (4600–6270) 4460 (3827–6015) 0.049
Haemoglobin level, median g/dL (IQR) 12.1 (10.1–13.5) 13.2 (11.5–14.1) 0.032
Platelet count, median cells/µL (IQR) 130,000 (81,000–281,000) 105,500 (69,000–141,500) 0.039
Platelet count < 150,000 cells/µL 19 (54.3) 34 (79.1) 0.016
Albumin level, median g/dL (IQR) 3.60 (3.20–4.00) 3.38 (3.02–3.73) 0.139
Creatinine level, median mg/dL (IQR) 0.79 (0.59–1.00) 0.95 (0.75–1.10) 0.030
LDH level, median value × IU/L (IQR) 267.0 (221.2–367.2) 370.0 (256.0–508.7) 0.028
AST level, median IU/L (IQR) 27.00 (20.00–32.50) 25.50 (19.90–43.75) 0.691
ALT level, median IU/L (IQR) 30.00 (18.00–43.20) 24.00 (18.00–48.00) 0.648
Total bilirubin level, median mg/dL (IQR) 0.83 (0.60–1.35) 1.22 (0.70–1.80) 0.086
INR, median (IQR) 1.08 (0.96–1.17) 1.12 (1.10–1.20) 0.019
APTT, median (IQR) 29.50 (25.10–37.07) 30.65 (26.27–32.97) 0.762
Glucose, median mg/dL (IQR) 91.5 (83.0–103.7) 97.0 (82.0–113.0) 0.468
  1. Values are no. (%) or no. positive/total no. (%) and median (interquartile range). Italicface indicates significance
  2. IQR interquartile range, PCR polymerase chain reaction, WBC white blood cells, LDH lactate dehydrogenase, AST aspartate aminotransferase, ALT alanine aminotransferase, INR international normalized ratio, APTT activated partial thromboplastin time